Retractable Technologies, Inc. (RVP)
NYSEAMERICAN: RVP · Real-Time Price · USD
0.7721
-0.0029 (-0.37%)
Dec 31, 2025, 4:00 PM EST - Market closed
Retractable Technologies Revenue
Retractable Technologies had revenue of $10.09M in the quarter ending September 30, 2025, a decrease of -2.52%. This brings the company's revenue in the last twelve months to $37.90M, down -0.95% year-over-year. In the year 2024, Retractable Technologies had annual revenue of $33.05M, down -24.19%.
Revenue (ttm)
$37.90M
Revenue Growth
-0.95%
P/S Ratio
0.61
Revenue / Employee
$166,963
Employees
227
Market Cap
23.11M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 33.05M | -10.55M | -24.19% |
| Dec 31, 2023 | 43.60M | -51.22M | -54.02% |
| Dec 31, 2022 | 94.82M | -93.56M | -49.67% |
| Dec 31, 2021 | 188.38M | 106.52M | 130.12% |
| Dec 31, 2020 | 81.86M | 40.07M | 95.86% |
| Dec 31, 2019 | 41.80M | 8.52M | 25.61% |
| Dec 31, 2018 | 33.27M | -1.22M | -3.53% |
| Dec 31, 2017 | 34.49M | 4.67M | 15.65% |
| Dec 31, 2016 | 29.83M | 274.44K | 0.93% |
| Dec 31, 2015 | 29.55M | -4.97M | -14.39% |
| Dec 31, 2014 | 34.52M | 3.74M | 12.13% |
| Dec 31, 2013 | 30.79M | -2.86M | -8.50% |
| Dec 31, 2012 | 33.64M | 1.54M | 4.80% |
| Dec 31, 2011 | 32.10M | -4.12M | -11.37% |
| Dec 31, 2010 | 36.22M | -2.76M | -7.09% |
| Dec 31, 2009 | 38.98M | 11.08M | 39.72% |
| Dec 31, 2008 | 27.90M | 1.61M | 6.12% |
| Dec 31, 2007 | 26.29M | 5.39M | 25.80% |
| Dec 31, 2006 | 20.90M | -259.46K | -1.23% |
| Dec 31, 2005 | 21.16M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
RVP News
- 1 day ago - Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders - Business Wire
- 6 weeks ago - Retractable Technologies, Inc. Results for the Periods Ended September 30, 2025 - Business Wire
- 6 weeks ago - Retractable Technologies, Inc. Receives Innovative Technology Designation from Vizient for EasyPoint Blood Collection Tube Holder with Needle - Business Wire
- 4 months ago - Retractable Technologies, Inc. Results for the Periods Ended June 30, 2025 - Business Wire
- 5 months ago - Retractable Technologies, Inc. Announces Reduction in Its Manufacturing Workforce - Business Wire
- 8 months ago - Retractable Technologies, Inc. Results for the Period Ended March 31, 2025 - Business Wire
- 9 months ago - Retractable Technologies, Inc. Announces Reduction in Workforce - Business Wire
- 9 months ago - Retractable Technologies, Inc. Reports Results for 2024 - Business Wire